Group One Trading
IBIO icon

Group One Trading’s iBio IBIO Stock Holding History

Group One Trading’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-156
Closed -$627 – 8229
2025
Q1 		$627 Hold
156
– – ﹤0.01% 7251
2024
Q4 		$382 Hold
156
– – ﹤0.01% 7025
2024
Q3 		$346 Hold
156
– – ﹤0.01% 6417
2024
Q2 		$329 Sell
156
-5
-3% -$11 ﹤0.01% 6492
2024
Q1 		$654 Buy
161
+111
+222% +$140 ﹤0.01% 6701
2023
Q4 		$69 Sell
50
-2
-4% -$9 ﹤0.01% 7214
2023
Q3 		$317 Buy
+52
New +$449 ﹤0.01% 7400
2023
Q1 		– Sell
-402
Closed -$10.3K – 7516
2022
Q4 		$3.57K Sell
402
-126
-24% -$4.26K ﹤0.01% 6471
2022
Q3 		$45K Buy
528
+108
+26% +$14.9K ﹤0.01% 5488
2022
Q2 		$55K Buy
420
+38
+10% +$5.71K ﹤0.01% 5470
2022
Q1 		$82K Sell
382
-50
-12% -$10.5K ﹤0.01% 5686
2021
Q4 		$119K Buy
432
+195
+82% +$74.4K ﹤0.01% 5571
2021
Q3 		$125K Buy
237
+179
+309% +$111K ﹤0.01% 5682
2021
Q2 		$44K Sell
58
-48
-45% -$35K ﹤0.01% 6698
2021
Q1 		$81K Buy
106
+49
+86% +$42.7K ﹤0.01% 5844
2020
Q4 		$30K Sell
57
-29
-34% -$23.6K ﹤0.01% 5293
2020
Q3 		$87K Buy
+86
New +$125K ﹤0.01% 4285

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's IBIO Position: Q2 2025 in Review

Group One Trading sold out of iBio (IBIO) in Q2 2025, closing a stake of 156 shares — an estimated $627 sold.

Group One Trading first reported a position in IBIO in Q3 2020 and held it in 17 quarters. The position peaked at $125K in Q3 2021. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Group One Trading reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 156 iBio shares in Q2 2025, an estimated $627.
  • Group One Trading first reported a position in iBio in Q3 2020 and held it in 17 quarters.
  • Group One Trading's iBio position peaked at $125K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.